TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jesse Dong, PhD
Vice President, Peptide Chemistry at Neon Therapeutics

Profile

Jesse Z. Dong, Ph.D., is Vice President, Peptide Chemistry at Neon Therapeutics. At Neon he is leading the peptide chemistry activities of developing neoantigen-targeted therapies, process development, and technical support for cGMP manufacturing. Prior to joining Neon, Jesse worked at Ipsen as Vice President of Compound Discovery, heading global Peptide Chemistry Division and leading peptide-based R&D programs. He is the sole inventor of TYMLOS™ (Abaloparatide), Setmelanotide, and Relamorelin, and a co-inventor of TBR-760 and TBR-065. These inventions led to the formations of Radius Health, Rhythm Pharmaceuticals, and Tiburio Therapeutics, respectively. Jesse is named inventor or co-inventor in 68 issued US patents and over 80 US patent applications. He is a co-author of over 150 publications and abstracts.

Jesse Dong, PhD's Network

Agenda Sessions

  • Chairman's Remarks

    , 08:55
  • Chairman's Remarks

    , 08:55
  • Chairman's Remarks

    , 08:55
  • Development of Personal Neoantigen Cancer Vaccine NEO-PV-01

    , 09:00
  • Development of Personal Neoantigen Cancer Vaccine NEO-PV-01

    , 09:00
  • Development of Personal Neoantigen Cancer Vaccine NEO-PV-01

    , 09:00

Speakers at this event